AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $173,000 | -46.8% | 76,324 | -20.5% | 0.02% | -48.6% |
| Q1 2021 | $325,000 | +550.0% | 96,016 | +438.4% | 0.04% | +362.5% |
| Q4 2020 | $50,000 | -74.9% | 17,833 | -77.5% | 0.01% | -75.0% |
| Q3 2020 | $199,000 | +40.1% | 79,240 | +321.8% | 0.03% | +14.3% |
| Q1 2020 | $142,000 | -34.0% | 18,787 | -51.5% | 0.03% | -24.3% |
| Q4 2018 | $215,000 | +121.6% | 38,767 | +252.8% | 0.04% | +184.6% |
| Q3 2018 | $97,000 | -73.4% | 10,989 | -69.9% | 0.01% | -76.4% |
| Q2 2018 | $365,000 | +50.2% | 36,534 | +43.0% | 0.06% | +52.8% |
| Q1 2018 | $243,000 | -41.4% | 25,556 | +21.0% | 0.04% | -46.3% |
| Q3 2017 | $415,000 | +174.8% | 21,115 | +45.4% | 0.07% | +63.4% |
| Q4 2016 | $151,000 | +2.7% | 14,518 | -26.0% | 0.04% | +2.5% |
| Q2 2016 | $147,000 | – | 19,629 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |